These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36717331)

  • 21. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early intervention for everyone? A review of cross-cultural issues and their treatment in ultra-high-risk (UHR) cohorts.
    Deriu V; Moro MR; Benoit L
    Early Interv Psychiatry; 2018 Oct; 12(5):796-810. PubMed ID: 29708310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distress in relation to attenuated psychotic symptoms in the ultra-high-risk population is not associated with increased risk of psychotic disorder.
    Power L; Polari AR; Yung AR; McGorry PD; Nelson B
    Early Interv Psychiatry; 2016 Jun; 10(3):258-62. PubMed ID: 25772939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial.
    Rietdijk J; Dragt S; Klaassen R; Ising H; Nieman D; Wunderink L; Delespaul P; Cuijpers P; Linszen D; van der Gaag M
    Trials; 2010 Mar; 11():30. PubMed ID: 20307268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability and validity of the Korean version of the comprehensive assessment of at-risk mental states.
    Lho SK; Oh S; Moon SY; Choi W; Kim M; Lee TY; Kwon JS
    Early Interv Psychiatry; 2021 Dec; 15(6):1730-1737. PubMed ID: 33543571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and predictive analysis for participants at ultra-high risk of psychosis: A comparison of three psychometric diagnostic interviews.
    Wang P; Yan CD; Dong XJ; Geng L; Xu C; Nie Y; Zhang S
    World J Clin Cases; 2022 Mar; 10(8):2420-2428. PubMed ID: 35434048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sources of clinical distress in young people at ultra high risk of psychosis.
    Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
    Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for schizophrenia in initial prodromal phase: Detecting the sub-threshold psychosis.
    Razali SM; Abidin ZZ; Othman Z; Yassin MA
    Asian J Psychiatr; 2015 Aug; 16():26-31. PubMed ID: 26182843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values.
    Bukenaite A; Stochl J; Mossaheb N; Schäfer MR; Klier CM; Becker J; Schloegelhofer M; Papageorgiou K; Montejo AL; Russo DA; Jones PB; Perez J; Amminger GP
    Schizophr Res; 2017 Nov; 189():69-74. PubMed ID: 28254243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability and validity of the Comprehensive Assessment of the At Risk Mental State, Italian version (CAARMS-I).
    Fusar-Poli P; Hobson R; Raduelli M; Balottin U
    Curr Pharm Des; 2012; 18(4):386-91. PubMed ID: 22239569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review.
    Savill M; D'Ambrosio J; Cannon TD; Loewy RL
    Early Interv Psychiatry; 2018 Feb; 12(1):3-14. PubMed ID: 28782283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subjective experience of social cognition in young people at Ultra-High Risk of psychosis: a 2-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
    Nord J Psychiatry; 2021 Feb; 75(2):97-108. PubMed ID: 32762506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Italian version of the 16-item Prodromal Questionnaire (PQ-16) and its psychometric features in help-seeking ultra-high-risk subjects and in the general population.
    Parabiaghi A; Rossi AA; Castelnovo A; Del Fabro L; Mannarini S; Percudani ME;
    Early Interv Psychiatry; 2024 Oct; 18(10):814-827. PubMed ID: 38375973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
    Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
    JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra-high risk in the UHR 1000+ cohort.
    Hartmann S; Dwyer D; Cavve B; Byrne EM; Scott I; Gao C; Wannan C; Yuen HP; Hartmann J; Lin A; Wood SJ; Wigman JTW; Middeldorp CM; Thompson A; Amminger P; Schlögelhofer M; Riecher-Rössler A; Chen EYH; Hickie IB; Phillips LJ; Schäfer MR; Mossaheb N; Smesny S; Berger G; de Haan L; Nordentoft M; Verma S; Nieman DH; McGorry PD; Yung AR; Clark SR; Nelson B
    World Psychiatry; 2024 Oct; 23(3):400-410. PubMed ID: 39279417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis.
    Mossaheb N; Becker J; Schaefer MR; Klier CM; Schloegelhofer M; Papageorgiou K; Amminger GP
    Schizophr Res; 2012 Nov; 141(2-3):210-4. PubMed ID: 22986044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.